Detailed Understanding of Patient Characteristics
To characterize disease severity and understand who also has prostate cancer
Granular View of Disease Progression and Patient Outcomes
Key variables such as Gleason score, PSA level and IPSS*
* In development
By the Numbers
Total de-identified patients with benign prostatic hyperplasia*
Total de-identified BPH patients who also have prostate cancer
Years median follow-up time
*Defined as patients in the AQUA Registry who are 18+ years old with the BPH ICD codes 600.01, 600.91, N40.1, N40.3 on 2 encounters, at least 2 valid patient notes starting in January 2015, and 1+ valid encounter after the first 2nd BPH diagnosis with 2+ valid notes. Data current to September 2025.
Meet with a Qdata Expert or Request a Data Count
Key Variables in Benign Prostatic Hyperplasia Research
Qdata BPH is a dataset that accurately identifies patients with benign prostatic hyperplasia (BPH) and provides insights on patient characteristics and outcomes. Verana Health provides curated variables extracted from EHR data to be utilized based on your research needs, including:
Gleason Score
Available for patients who also have prostate cancer. Curated from clinical notes based on biopsy samples and details the aggressiveness of cancer cells.
PSA Level
Curated from clinical notes and helps clinicians determine whether the cancer is high-risk.
IPSS*
International Prostate Symptom Score (IPSS) is an 8 question screening tool to screen, diagnose, track symptoms and suggest management of BPH.
*In development
Talk to a Qdata Expert
Take a minute to submit your contact information and one of our team members will reach out to you.